We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Savara
SVRA
$1.18B
| $281K | ﹤0.01% |
37,090
+13,120
| +55% | +$118K |
|
|
APTX
2577
DELISTED
Aptinyx Inc. Common Stock
APTX
| $280K | ﹤0.01% |
16,944
+7,033
| +71% | +$166K |
|
2578
Century Casinos
CNTY
$34M
| $279K | ﹤0.01% |
37,713
+11,747
| +45% | +$80.2K |
|
2579
Metropolitan Bank Holding Corp
MCB
$1.15B
| $278K | ﹤0.01% |
9,023
+2,966
| +49% | +$109K |
|
2580
Clear Channel Outdoor Holdings
CCO
$1.23B
| $277K | ﹤0.01% |
53,461
+15,045
| +39% | +$84.8K |
|
2581
Minerva Neurosciences
NERV
$202M
| $276K | ﹤0.01% |
5,114
+1,667
| +48% | +$122K |
|
2582
Turning Point Brands
TPB
$1.71B
| $276K | ﹤0.01% |
10,135
+3,277
| +48% | +$115K |
|
|
CLPR
2583
Clipper Realty
CLPR
$45.1M
| $275K | ﹤0.01% |
21,034
+5,824
| +38% | +$76.4K |
|
2584
Goldgroup Mining Inc.
GORO
$160M
| $275K | ﹤0.01% |
68,710
+21,887
| +47% | +$98.6K |
|
2585
Entravision Communication
EVC
$1.06B
| $274K | ﹤0.01% |
94,032
+26,857
| +40% | +$105K |
|
|
CDMO
2586
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $274K | ﹤0.01% |
66,851
+23,095
| +53% | +$121K |
|
|
CVLY
2587
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $274K | ﹤0.01% |
13,522
+4,113
| +44% | +$99.6K |
|
|
CNBKA
2588
DELISTED
Century Bancorp Inc/Mass
CNBKA
| $274K | ﹤0.01% |
4,051
+1,228
| +43% | +$94.6K |
|
|
REV
2589
DELISTED
Revlon, Inc.
REV
| $274K | ﹤0.01% |
+10,878
| New | +$268K |
|
|
RPT
2590
Rithm Property Trust
RPT
$94.2M
| $273K | ﹤0.01% |
3,908
+1,190
| +44% | +$89.5K |
|
2591
UFP Technologies
UFPT
$2.44B
| $272K | ﹤0.01% |
9,049
+2,805
| +45% | +$96K |
|
|
CBMG
2592
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $272K | ﹤0.01% |
15,377
+5,074
| +49% | +$86.2K |
|
2593
SAP
SAP
$229B
| $271K | ﹤0.01% |
2,725
-144
| -5% | -$15.3K |
|
|
FCBP
2594
DELISTED
First Choice Bancorp Common Stock
FCBP
| $270K | ﹤0.01% |
+11,929
| New | +$278K |
|
2595
Duluth Holdings
DLTH
$160M
| $269K | ﹤0.01% |
10,678
+3,391
| +47% | +$96.9K |
|
2596
First Bank
FRBA
$456M
| $269K | ﹤0.01% |
22,163
+6,748
| +44% | +$80.7K |
|
2597
Norwood Financial Corp
NWFL
$369M
| $269K | ﹤0.01% |
8,165
+2,577
| +46% | +$91.8K |
|
|
VWTR
2598
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $268K | ﹤0.01% |
29,282
+8,270
| +39% | +$87.5K |
|
|
AGEN
2599
Agenus
AGEN
$308M
| $267K | ﹤0.01% |
5,707
+1,909
| +50% | +$79.6K |
|
2600
RCI Hospitality Holdings
RICK
$202M
| $266K | ﹤0.01% |
11,932
+3,939
| +49% | +$98.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.